Claris Lifesciences (Delisted) share news and announcements

BSE: 533288

Last traded ₹396.55 on 14 Mar 2018

Delisted on 22 Mar 2018.

Claris Lifesciences share news and announcements

337 announcements, routine notices left out, newest first. Page 2 of 7.

Jun 2017
- 1 Jun · Business
  Claris Lifesciences Limited (CLL) along with its wholly owned subsidiary Claris Injectables Limited (CIL) announced today that it underwent a successful USFDA Pharmacovigilance (PV) audit .... (opens in a new tab)
May 2017
Apr 2017
- 13 Apr · Compliance Certificate For The Half Year Ended March 31, 2017
  Compliance Certificate under Regulation 7(3) of SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015 for the half year ended March 31, 2017 (opens in a new tab)
- 10 Apr · Shareholding for the Period Ended March 31, 2017
  Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....
- 10 Apr · Compliance For The Half Year Ended March 31, 2017
  Please find enclosed herewith Certificate pursuant to Regulation 40(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended March 31, 2017. (opens in a new tab)
- 10 Apr · Statement Of Investor Complaints For The Quarter Ended March 31, 2017
  Please find enclosed Statement of Investor Complaints for the quarter ended on March 31, 2017, pursuant to Regulation 13(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (opens in a new tab)
- 7 Apr · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Athanas Enterprise Pvt Ltd (opens in a new tab)
Feb 2017
- 20 Feb · Results
  Details of Voting results of Postal Ballot, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
- 17 Feb · Results
  Details of Voting results at the Postal Ballot of the Company, under Regulation 44(3) of SEBI (LODR) Regulations, 2015 along with .... (opens in a new tab)
- 14 Feb · Results
  1. Standalone Financial Results for the period ended December 31, 2016 2. Consolidated Financial Results for the period ended .... (opens in a new tab)
- 3 Feb · Board meeting
  Meeting of the Board of Directors of the Company will be held on February 14, 2017, inter alia, to consider, approve and take on record the .... (opens in a new tab)
Jan 2017
- 18 Jan · Meeting
  Advertisement of Postal Ballot Notice published on January 18, 2017, in Newspaper. (opens in a new tab)
- 17 Jan · Meeting
  Notice of Postal Ballot. (opens in a new tab)
- 12 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation .... (opens in a new tab)
- 11 Jan · Shareholding for the Period Ended December 31, 2016
  Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
- 3 Jan · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Athanas Enterprises Pvt Ltd (opens in a new tab)
Dec 2016
- 29 Dec · Disclosure
  Exchange has received the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Athanas Enterprises Pvt Ltd (opens in a new tab)
- 15 Dec · Board meeting
  Board of Directors of the Company at the meeting held on December 15, 2016 (commenced at 5:00 PM and concluded at 6:30 PM) has approved .... (opens in a new tab)
- 15 Dec · Claris Lifesciences Limited to Sell Its Global Generic Injectables Business to Baxter for US$ 625 million
  Press Release dated December 15, 2016, titled "Claris Lifesciences Limited to Sell Its Global Generic Injectables Business to Baxter .... (opens in a new tab)
- 8 Dec · Results
  1. Standalone Financial Results for the period ended September 30, 2016 2. Consolidated Financial Results for the period .... (opens in a new tab)
Nov 2016
- 28 Nov · Board meeting
  Pursuant to the SEBI Circular dated July 05, 2016, the SEBI has extended time line for submitting the financial results for the quarter ended .... (opens in a new tab)
Oct 2016
- 26 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 26 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 26 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 25 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 25 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 21 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 20 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 19 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 19 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 19 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 18 Oct · Disclosure
  IDBI Trusteeship Services Ltdhas submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 17 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 14 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
  Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended September 30, 2016, under Regulation .... (opens in a new tab)
- 13 Oct · Shareholding for the Period Ended September 30, 2016
  Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....
- 13 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 10 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 7 Oct · Disclosure
  Abellon Energy Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE (opens in a new tab)
- 7 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)
- 7 Oct · Disclosure
  IDBI Trusteeship Services Ltd has submitted the disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 (opens in a new tab)